Stocks On the Move: Celldex Therapeutics, Inc., Inc, and Nu Skin Enterprises, Inc.

CLDX, COUP, and NUS are moving sharply in Wednesday's trading

Nov 5, 2014 at 11:09 AM
facebook twitter linkedin

Around midday, three of the top market movers are biopharmaceutical name Celldex Therapeutics, Inc. (NASDAQ:CLDX), digital promotion platform Inc (NYSE:COUP), and anti-aging products marketer Nu Skin Enterprises, Inc. (NYSE:NUS). Here's a quick roundup of how CLDX, COUP, and NUS are performing on the charts so far.

  • CLDX has tumbled 11.5% this morning, despite a slimmer-than-expected third-quarter loss and revenue beat. At last check, the shares are perched at $14.67, bringing their year-to-date loss beyond 39%. In options land, traders have been buying to open puts over calls at a near-extreme rate in recent weeks. Specifically, during the past 10 days, Celldex Therapeutics, Inc. has racked up a put/call volume ratio of 1.24 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Not only does this number reveal that long puts outstrip long calls, it also ranks just 1 percentage point from a 12-month high.

  • COUP has tacked on 24.5% to trade at $15.49, after exceeding the Street's expectations in the earnings confessional. In fact, since hitting a record low of $11.61 in late August, the Wall Street rookie has rallied more than 33%. Nevertheless, just one brokerage firm is currently following Inc., and 7.4% of the equity's float is sold short, representing more than six sessions' worth of pent-up buying demand, at average daily trading levels. Should the shares maintain their recent positive momentum, a round of bullish initiations and/or a short-covering rally could be in the cards.

  • Finally, NUS plunged to an annual low of $39.46 earlier, and was last seen 15% south of breakeven at $42.84. Impacting the security today was a reduced current-quarter forecast, which overshadowed a third-quarter earnings and revenue beat. Year-to-date, Nu Skin Enterprises, Inc. is now sitting on a brow-raising deficit of 69%. Elsewhere, at the ISE, CBOE, and PHLX, the stock's 10-day put/call volume ratio of 1.00 ranks higher than 70% of all other readings from the past year -- suggesting options traders have been buying to open puts over calls at a faster-than-usual clip lately.

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners